BiotechTube
Home/Tagworks Pharmaceuticals/Keith Orford, MD/PhD
KO

Keith Orford, MD/PhD

CMO

Tagworks Pharmaceuticals

Therapeutic Areas

Oncology

Tagworks Pharmaceuticals Pipeline

DrugIndicationPhase
TGW101Advanced Solid Tumors (TAG72+)Phase 1
TGW211HER2+ TumorsPhase 0/1

Leadership Team at Tagworks Pharmaceuticals

KM
Ken Mills
CEO
MR
Marc Robillard, PhD
CSO & Co-founder
RR
Raffaella Rossin, PhD
Head of Discovery & Co-founder
View full Tagworks Pharmaceuticals profile